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Isolation, Characterization, and Mapping of a Human Acid 
{J-Galactosidase cDNA 
YOSHIMI YAMAMOTO,•,§ CYNTHIA A. HAKE,* BRIAN M. MARTIN,t KEITH A. KRETZ,* 
AMELIA J. AHERN-RINDELL,* SUSAN L. NAYLOR,t MICHAL MUDD,t and JOHNS. O'BRIEN* 
ABSTRACT 
A >.gtll human testicular cDNA library was screened with degenerate oligonucleotide probe mixtures based 
on amino acid sequence data generated from cyanogen bromide fragments and tryptic fragments of purified 
human {3-galactosidase. Six positive clones were identified after screening 2 x 106 plaques. The sequences of 
these six clones were determined and found to be derived from two different cDNAs. The sequence of the 
longest of these cDNAs is nearly identical to that recently determined by Oshima et al. (1988). It codes for a 
76-kD protein and all 11 peptides that were generated from the purified enzyme. The second clone is shorter 
by 393 bp in the central portion of the coding region. Analysis by Northern blotting revealed the presence of 
a single mRNA species of 2.45 kb in lymphoblasts and testicular tissue. It is deduced from the amino acid se-
quence data that proteolytic processing of the precursor form of {3-galactosidase must occur by cleavage in 
the carboxy-terminal portion of the polypeptide perhaps around amino acid 530 at a uniquely hydrophilic se-
quence. Using a probe generated from th~ 3' region of the cDNA, we have mapped the locus coding for hu-
man {3-galactosidase to chromosome 3p21-3pter. 
INTRODUCTION 
JQ-D-GALACTOSIDASE (EC 3.2.1.23) is a lysosomal hy-
tJ drolase responsible for the removal of terminal galac-
tosyl moieties from glycoproteins and glycolipids, most 
notably GMl-ganglioside. The primary defect in the meta-
bolic storage diseases GMl-gangliosidosis and Morquio B 
syndrome is a deficiency of this enzyme (for review, see 
O'Brien, 1989). 
The structural gene for 13-galactosidase has been local-
ized to the short arm of human chromosome 3 (Shows et 
al., 1979; Naylor et al., 1982). In normal human fibro-
blasts, an 84-kD precursor is synthesized and processed via 
intermediates into a mature 64-kD monomer (Nanba et al., 
191!8). In the lysosome, a "protective protein" interacts 
with 13-galactosidase monomers effecting their multimer-
ization into a high-molecular-weight aggregate of 600-700 
kD (Hoogeveen et al., 1983). The aggregated 13-galactosi-
dase plus protective protein and another lysosomal en-
zyme, a-neuraminidase (EC 3 .2. l.18), form a lysosomal 
membrane-bound complex. Formation of this complex is 
necessary to protect 13-galactosidase from intralysosomal 
degradation by proteases and to stabilize a-neuraminidase 
(Hoogeveen et al., 1983; Verheijen et al., 1985; Nanba et 
al., 1987). 
The existence of the complex has made it difficult to iso-
late and purify 13-galactosidase. This difficulty, along with 
the fact that lysosomal enzymes in general are encoded by 
mRNAs that are present in extremely low abundance, has 
hampered attempts to clone the 13-galactosidase gene until 
now. 
The sequence of a full-length cDNA coding for 13-galac-
tosidase was reported recently by Oshima et al. (1988). We 
also have cloned a full length human cDNA encoding 13-ga-
lactosidase whose sequence agrees almost completely with 
theirs. In addition, we have identified the sequence which 
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is removed by proteolytic processing by structural analysis 
of pure enzyme, mapped the cDNA to chromosome 3p21-
3pter and determined the size of the ,6-galactosidase 
mRNA. 
MATERIALS AND METHODS 
Purification and amino acid sequence analysis 
of {3-galactosidase 
Human liver ,6-galactosidase was purified as described 
(Norden et al., 1974; Miller et al., 1976) with minor modi-
fications (Yamamoto et al., 1982). Briefly, ,6-galactosidase 
was purified by chromatography on concanavalin A-Seph-
arose, Sepharose-p-aminophenyl-,6-o-thiogalactoside, 
Sepharose-6B, and octyl-Sepharose. The purified prepara-
tion consisted of ,6-galactosidase protein (64 kD) and pro-
tective protein (32 kD and 20 kD) as described previously 
(Yamamoto et al., 1982). Homogeneous ,6-galactosidase 
protein (64 kD) was obtained by reverse-phase HPLC on a 
Vydac C4 column (4.6 mm x 25 cm). Before injection, the 
sample was heated at 100°C for 5 min in 2% NaDodSO. 
and 5% 2-mercaptoethanol. A linear gradient of acetoni-
trile (0-80%) in water containing 0.1 "lo trifluoroacetic acid 
was used. Three major peaks were collected; these were 
found after gel electrophoresis to correspond to proteins 
of 20, 32, and 64 kD. The peak containing the 64-kD pro-
tein gave a single band on NaDodSO. polyacrylamide gel 
electrophoresis. The 64-kD protein was cleaved with cyan-
ogen bromide (CNBr) or digested with trypsin as follows. 
Trypsin 
1 Tyr Phe Ala Leu Arg 
2 Glu Ser Ile Leu Leu Arg 
3 Met Phe Glu Ile Asp Tyr Ser Arg 
4 Gln His Tyr Gly Phe Val Leu Tyr 
5 bl. Ile Ser Gly Ser Ile His Tyr 
6 Val Aan Tyr Gly Ala bl. Ile Aan 
7 Ala Tyr Val Ala Val Asp Gly Ile 
8 Phe Ser Asp Pro Asp Try Leu Ala 
51 Aan Aan Val Ile Thr Leu Aan Ile 
10 Thr Thr Leu Pro Gln Asp Ill Ser 
Cyanogen Bromide 
11 Phe Ile Gly Gly Thr Aan Phe Ala 
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For CNBr cleavage, pure human ,6-galactosidase was 
dissolved in 70% formic acid and then a lOOx molar ex-
cess of solid CNBr was added. After incubation overnight 
at room temperature, 9 volumes of water were added and 
the reaction products were lyophilized. CNBr cleaved pep-
tides were separated by NaDodSO. polyacrylamide gel 
electrophoresis and electroblotted onto a polyvinylidene 
difluoride membrane (Immobilon Transfer, Millipore) as 
described by Matsudaira (1987). Protein was stained with 
Coomassie blue and well separated bands were cut out and 
sequenced (Matsudaira, 1987). 
Probe Bl 
A Thr Asn Phe Ala Tyr Cys Asn Gly Ala 
B 5' ACN AA!!. uu.!!. c c GCN UA£ UG£ AA£ GGN c c c GC 3' 
c 3' TGN 
A A 
TTG AAG CGN A~ AC! TT! cc~ CG 5' 
Probe B2 
A Gln His Tyr Gly Phe Val Leu Tyr Arg 
B 5' CA~ CA£ UA£ G C C GGN uu~ GUN CUN UA~ CG 3' 
c 3' 
T A A 
GTC GT;; AT;; CCN AA! CAN GA~ AT! GC 5' 
FIG. 1. Probe mixtures used to screen for human ,6-
galactosidase. The two peptide sequences listed were used 
to synthesize degenerate oligonucleotide probe mixtures as 
shown. A, Amino acid sequence; B, deduced nucleotide 
sequence; C, complimentary oligonucleotide sequence syn-





Ala Val Lya 
Thr Gly Lya 
Aan Pro ~ Pro Leu Ser 
Tyr ~ Aan Gly Ala Aan Ser Pro Tyr Ala 
FIG. 2.· Amino acid sequences obtained after cleavage of purified human ,6-galactosidase with trypsin or CNBr. The 
underlined residues differ from those determined from the nucleotide sequence. It is assumed that the potential glyco.syla-
tion site in trypsin fragment 9 is not glycosylated because it was identified during amino acid sequencing. 
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Trypsin digestion was performed in 2 M urea, 0.1 M 
Tris-HCI pH 8.0, and 20 mM methylamine-HCI with 2% 
wt/wt trypsin (Boehringer-Mannheim, sequencing grade) 
{1-galactosidase at 37°C overnight. Separation of tryptic 
peptides was carried out by reverse-phase HPLC on a 
Brownlee Aquapore column (RP-300, 2.1 mm x IO cm) 
using a gradient of acetonitrile in 0.1 07o trifluoroacetic 
acid. Twenty-one well-separated peaks were collected and 
used for amino acid sequence analysis. Amino acid se-
quencing was accomplished using an Applied Biosystems 
model 470A gas-phase sequencer equipped with a model 
120A on-line PTH-amino acid analyzer. 
Oligonucleotide probe synthesis 
Two 26-bp-long degenerate oligonucleotide probe mix-
tures were synthesized by the phosphoramidite method 
(Matteucci and Caruthers, 1981) based on the amino acid 
sequence of two /1-galactosidase peptides (Fig. l). The 
oligonucleotides were 5'-end-labeled using T4-polynucleo-
tide kinase and ['y-32P]ATP as follows: 5 µ.g of oligonucleo-
tide probe were resuspended in 200 mM Tris-HCI pH 7.4, 
IO mM MgCI,, and 40 mM 2-mercaptoethanol with 250 
µ.Ci ['y-32P]A TP and 10 units of T 4-polynucleotide kinase 
in a total reaction volume of 50 µ.I. The reaction mixture 
was incubated at 37°C for l hr and the reaction was 
stopped by heating at 60°C for 5 min. Unincorporated 
R1 
[ 32P]ATP was removed from the labeled sample by passage 
through a Nensorb column (Dupont) using the manufac-
turer's instructions. The specific activity obtained was 5-IO 
x IO" cpm/ µ.g. 
Library screening 
A human testis cDNA library constructed in >.gtl l was 
purchased from Clontech. After plating on E. coli YI090, 
a total of 2 x I0° plaques were screened. 
The phage DNA was transferred to nitrocellulose (Davis 
et al., 1986) and fixed by heating at 80°C under vacuum 
for 2 hr. The filters were prehybridized at 65°C for 4 hr in 
a solution containing 6 x SSC (sodium chloride/sodium 
citrate buffer), 0.05% sodium pyrophosphate, 0.5% 
NaDodS04 , 100 µ.g/ml of denatured salmon sperm DNA, 
and lOx Denhardt's solution (Maniatis et al., 1982). 
Hybridization was carried out at 37°C overnight in the 
same solution (without NaDodSO.) as above with 20% 
formamide and 32P-labeled probe mixture (4-IO x 106 
cpm/ml). The filters were rinsed three times with 6 x SSC/ 
0.05% sodium pyrophosphate and washed two times for 
30 min each in the same solution at room temperature. The 
filters were then rinsed with Me.NCI wash solution (3 M 
tetramethylammonium chloride, 50 mM Tris-HCI pH 8.0, 























FIG. 3. Structure of human {1-galactosidase cDNAs. I and II represent the two cDNA structures determined from se-
quencing the clones shown. The open box represents the open reading frame while the· solid lines represent untranslated 
regions. The numbered dashes (-) under the cDNA structure indicate the location of the 11 sequenced peptides from Fig. 
2. The individual clones (2, 6, 9, 16, 19, and 23) are denoted. RI denotes the position of the internal Eco RI site. The 
cross-hatched regions denote the region unique to each structure as discussed in the text. 
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goat \cgggcgcgaagcggccggcc\gggcgccgac\gcagagccgggaggctggtggtc ATG CCG GGG TTC CTG GTT CGC ATC CTCICIT I 
•et pro gly phe leu val arg i le leu leu 
~ * 
CTGl.C.TGICTG GTT CTG CTG CTT CTG GGC CCT ACG CGC GGC TTG CGC AAT GCC ACC CAG AGG ATG TTT GAA ATT GAC TAT AGC CGG GAC TCC 
leu leu le1.1 vol leu leu leu leu gly pro thr org gly leu arg osn ala thr gin arg 11t phc ply I le 939 t11r 3cr grg a1p 1er 






phe leu ly1 asp gly gin pro phe arg tur j le acr glu 'Cr j le b!:s tyr ;er grg val pro arg phe tyr trp ly1 a1p arg leu leu 70 
5 
AAG ATG AAG ATG GCT GGG CTG AAC GCC ATC CAG ACG TAT GTG CCC TGG AAC TTT CAT GAG CCC TGG CCA GGA CAG TAC CAG TTT TCT GAG 360 
ly1 •et ly1 1et ala gly leu a1n ala i le gin thr tyr vol pro trp 01n phe hi1 glu pro trp pro gly gin tyr gin phe 1er glu 100 
GAC CAT GAT GTG GAA TAT TTT CTT CGG CTG GCT CAT GAG CTG GGA CTG CTG GTT ATC CTG AGG CCC GGG CCC TAC ATC TGT GCA GAG TGG 150 
01p hi1 a1p val glu tyr phe leu arg leu ala hi1 glu leu gly leu leu val I le Jeu arg pro gly pro tyr i le cy1 ala glu trp IJO 
GAA ATG GGA GGA TTA CCT GCT TGG CTG CTA GAG AAA GAG TCT ATT CTT CTC CGC TCC TCC GAC CCA GAT TAC CTG GCA GCT GTG GAC AAG 510 
glu 1et g/y gly Jeu pro ala trp leu leu glu fy3 ply :1er j le !cu Icy grg 1er !!'C pip prp a3g lur lgy gig gig yg! OIP ly1 160 
2 
TGG TTG GGA GTC CTT CTG CCC AAG ATG AAG CCT CTC CTC TAT CAG AAT GGA GGG CCA GTT ATA ACA GTG CAG OTT GAA AAT GAA TAT GGC 630 
trp leu gly val leu leu pro lys •et ly1 pro leu leu tyr gin asn gly gly pro val ile thr val gin val glu a,n glu tyr gly 190 
AGC TAC TTT GCC TGT GAT TTT GAC TAC CT.ti....l:Ji.C. TC CTG CAG AAG CGC TTT CGC CAC CAT CTG GGG GAT GAT GTG GTT CTG TTT ACC ACT 720 
'er tyr phe ala cy' a'p phe a'p tyr leu arg phe leu gin ly' arg phe arg hl1 hi' leu gly a'p a'p val val leu phe thr thr 220 
* GAT GGA GCA CAT AAA ACA TTC CTG AAA TGT GGG GCC CTG CAG GGC CTC TAC ACC ACG GTG GAC TTT GGA ACA GGC AGC AAC ATC ACA GAT 610 
aop gly ala hi• Iyo thr phe leu Iyo cyo gly ala leu gin gly leu \yr thr thr val aop phe glw \hr gly oor aon i le \hr aop 250 
GCT TTC CTA AGC CAG AGG AAG TGT GAG CCC AAA GGA CCC TTG ATC AAT TCT GAA TTC TAT ACT GGC TGG CTR GAT CAC TGG GGC CAA CCT 900 
ala phe leu oer gin arg Iyo cyo glu pro Iyo gly pro leu lie aon oer glu phe \yr \hr gly \rp leu aop hio trp glw gin pro 260 
CAC TCC ACA ATC AAG ACC GAA GCA GTG GCT TCC rec CTC TAT GAT ATA CTT GCC CGT GGG GCG AGT GTG AAC TTG TAC ATG TTT ATA GGT 990 
hi' 'er thr Ile ly' thr glu ala val ala 'er 'er leu tyr G9P lie leu ala arg gly ala 'er val a'n leu tyr •et phe .Ll.c......glu, 310 
11 
GGG ACC AAT TTT GCC TAT TGG AAT GGG GCC AAC TCA CCC TAT GCA GCA CAG CCC ACC AGC TAC GAC TAT GAT GCC CCA CTG AGT GAG GCT 1060 
qly the 930 pbe gig t11r trp 930 gl11 gig a'o 3er grg tur gig ala gin pro thr 'er tyr a9p tyr a'p ala pro leu 'er glu a/a 3~0 
GGG GAC CTC ACT GAG AAG TAT TTT GCT CTG CGA AAC ATC ATC CAG AAG TTT GAA AAA GTA CCA GAA GGT CCT ATC CCT CCA TCT ACA CCA 1170 
gly a'P leu thl" glu ly' tur phc gig Icy grg a'n i le i le gin ly' phe glu ly9 val Org glu gly pro i le pro pro 'er thr pro 370 
AAG TTT GCA TAT GGA AAG GTC ACT TTG GAA AAG TTA AAG ACA GTG GGA GCA GCT CTG GAC ATT CTG TGT CCC TCT GGG CCC ATC AAA AGC 1260 
ly' phe ala tyl" gly ly' val thr leu glu ly' leu lys thl" val gly ala ala leu a'p ile leu cy9 pro 9er gly pro i le ly1 9er 100 
CTT TAT CCC TTG ACA TTT ATC CAG GTG AAA CAG CAT TAT GGG TTT GTG CTG TAC CGG ACA ACA CTT CCT CAA GAT TGC AGC AAC CCA GCA 1350 
leu tyr pro leu thr phe i le gin val ly' gin bj3 tyr ply ohc ugl Icy t11r QCQ the thr Icy PCP pip Q'P cu3 3er 930 oro gig ~30 
10 
CCT CTC TCT TCA CCC CTC AAT GGA GTC CAC GAT CGA GCA TAT GTT GCT GTG GAT GGG ATC CCC CAG GGA GTC CTT GAG CGA AAC AAT GTG 1110 
peg !ey 3cr 'er pro leu asn gly val hi' a'p arg gig tyr ugl gig ygt 9'0 gll1 j le nrg pin gly vol leu glu arg 930 a;rn vgl 160 
* 7 
ATC ACT CTG AAC ATA ACA GGG AAA GCT GGA GCC ACT CTG GAC CTT CTG GTA GAG AAC ATG GGA CGT GTG AAC TAT GGT GCA TAT ATC AAC 1530 
j le thr ley gsn j le tbr ply lu3 ala gly a/a thr leu a'p leu leu val glu o'n •et gly arg ygl 930 tyr gll1 gig tur j le 930 ~90 
* GAT TTT AAG GGT TTG GTT TCT AAC CTG ACT CTC AGT TCC AAT ATC CTC ACG GAC TGG ACG ATC TTT CCA CTG GAC ACT GAG GAT GCA GTG 1620 
~ ly' gly leu vol ser cnn leu thr leu 'er 1er a'n i le leu thr o'P trp thr i le phe pro leu a'P thl" glu 09P ala uol 520 
* * CGC AGC CAC CTG GGG GGC TGG GGA CAC CGT GAC AGT GGC CAC CAT GAT GAA GCC TGG GCC CAC AAC TCA TCC AAC TAC ACG CTC CCG GCC 1710 
arg 'er hi' leu gly gly trp gly hi' arg a1p 1er gly hi' hi' 01p glu ala trp ala hi' a'n 'er 'er a'n tyr thr leu pro ala 550 
* 
TTT TAT ATG GGG AAC TTC TCC ATT CCC AGT GGG ATC CCA GAC TTG CCC CAG GAC ACC TTT ATC CAG TTT CCT GGA TGG ACC AAG GGC CAG 1600 
phe tyr •et gly asn phe 'er i le pro ser gly i le pro a'p leu pro gin a'P thr phe i le gin phe pro gly trp thr lys gly gin 560 
GTC TGG ATT AAT GGC TTT AAC CTT GGC CGC TAT TGG CCA GCC CGG GGC CCT CAG TTG ACC TTG TTT GTG CCC CAG CAC ATC CTG ATG ACC 1690 
val trp i le a'n gly phe a'n leu gly arg tyl" trp Pl"O ala arg gly pro gin leu thr leu phe val pro gin hi' i le leu •et thr 610 
TCG GCC CCR AAC ACC ATC ACC GTG CTG GAA CTG GAG TGG GCA CCC TGC AGC AGT GAT GAT CCA GAA CTA TGT GCT GTG ACG TTC GTG GAC 1960 
Ser ala pro o'n lhr i le thr uol leu glu leu glu trp ala pro cy' 9er 'er 09p a'p pro glu leu cys ola ual thr phe val o'p 610 
AGG CCA GTT ATT GGC TCA TCT GTG ACC TAC GAT CAT CCC TCC AAA CCT GTT GAA AAA AGA CTC ATG CCC CCA CCC CCG CAA AAA AAC AAA 2070 
ol"g pro val i le gly ser 'er vol thr tyr o'p hi' pro 9er ly' pro vol glu ly' erg leu •et pro pro pro pro gin ly' osn ly' 670 
GAT TCA TGG CTG GAC CAT GTA TGA TGA TGA aagcctgtg\ctttgagggat\ctaccctgaacatacctcacaga\cc\ccctgtcatgccacatttcactga\tggaa 2179 
aop oer \rp leu aop hio val OPA OPA OPA 677 
lgtggaaotggaaaoggaatttaggatgtgcotttlcacctgaggtttccctgcatccctgcagtgccaaogccccaccttcogggoccacctggaatgtgtgaggggctgacagcaca 2296 
gt aocgt gcotocat at ct gcogggctggoot ggaagcl t taaaggt ggtagtgat t t l tat t t t ggaogaot cat gt t acct t t t l gt t~at t t gcccgaat le 2~09 
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times for 20 min each with the Me.NCI wash solution at 
55°C. The dried filters were exposed to Kodak X-Omat 
film at - 70°C with an intensifying screen. Six positive 
clones were isolated after five rounds of screening and 
used for nucleotide sequence analysis. 
Cloning and sequencing 
Inserts from the positive clones were obtained by Eco RI 
digestion of large-scale phage preparations according to 
Maniatis et al. (1982). The inserts were separated on 0.70Jo 
agarose gels and were electroeluted from the gels using an 
IBI Model UEA electoeluter according to the manufac-
turer's instructions. The inserts were ligated into pB!ue-
script KS n- (Stratagene) and unidirectional deletions were 
made as suggested by the manufacturer. Sequencing was 
performed using modified T7-DNA polymerase (Se-
quenase, US Biochemicals) according to instructions for 
double-stranded templates. 
Northern blotting and hybridization 
Poly(A)RNA was prepared from human lymphoblasts 
and human testicular tissue using the Fast-Track RNA iso-
lation kit (Invitrogen) as recommended by the manufac-
turer. Approximately 1 µ.g of this RNA was separated on a 
1 OJo formaldehyde/agarose gel (Maniatis et al., 1982) and 
blotted onto a nylon membrane (Schleicher & Schuell). 
RNA probes for hybridization were prepared using the T3 
promoter of the pB!uescript vector with T3-polymerase 
and [32P]CTP. Hybridization was carried out in 500Jo 
formamide/5 x SSC at 55°C overnight according to the 
method supplied with the vector. The filter was washed at 
65°C in 2x SSC/O.lOJo NaDodSO. twice for 15 min each, 
and twice in 0.1 x SSC/O.lOJo NaDodSO. for 15 min each. 
The filter was exposed to Kodak X-Omat film for 2 days at 
- 70°C with an intensifying screen. 
Chromosomal mapping 
Human-rodent somatic cell hybrids were produced by 
the fusion of human fibroblasts or lymphocytes with 
mouse cell lines (Rag, LMTK- or L TP) containing select-
able markers (see references in Naylor et al., 1983). Each 
hybrid line was karyotyped and assayed for isozyme mark-
ers at the time of DNA harvest (Shows et al., 1982). Two 
series of hybrids segregated portions of chromosome 3: the 
TSL series was made from an individual with a reciprocal 
3;17 translocation [GM2808-46,XX,t(3;17)(p21;p13)] and 
the XTR series from an individual with a reciprocal X;3 
translocation [GM194-46,X,t(X;3)(q28;q21)] (Naylor et 
al., 1982). 
RESULTS 
Purification of human /)-galactosidase by column chro-
matography yielded a mixture of three proteins. The final 
separation of /)-galactosidase was only accomplished after 
heating at 100°C for 5 min in a solution of 20Jo NaDodSO. 
and 50Jo 2-mercaptoethanol followed by HPLC separation. 
After either CNBr cleavage or trypsin digestion, amino 
acid sequence analysis of purified human /)-galactosidase 
fragments yielded one CNBr fragment sequence and ten 
tryptic fragment sequences (Fig. 2). Many of the CNBr 
fragments and trypsin fragments did not yield enough pro-
tein to analyze, whereas some of the fragments were multi-
ples upon further analysis and could not be used. 
Two degenerate oligonucleotide probe mixtures were 
generated from appropriate regions of two of the amino 
acid sequences (Fig. 1). Screening of the human testicular 
cDNA library with the end-labeled probes yielded six posi-
tive clones, and sequencing of these clones revealed the 
presence of two different cDNA species (Fig. 3). Examina-
tion of the sequence of clone 23 revealed that a 485-bp re-
gion of clone 16 had been replaced by a 92-bp segment also 
coding for an uninterrupted open reading frame. The se-
quence of clone 16 was used to deduce the amino acid se-
quence of human /)-galactosidase (Fig. 4). This sequence 
was nearly identical to that recently reported by Oshima et 
al. (1988). 
The presence of two different cDNA sequences, both 
coding for uninterrupted open reading frames, led us to 
examine the mRNA species present. Northern blotting and 
hybridization using an RNA probe generated from clone 6 
(Fig. 3) revealed the presence of a single RNA species of 
2.45 kb in human lymphoblasts and human testicular tis-
sue (Fig. 5). 
Chromosomal localization was determined using clone 6 
to screen a series of 28 hybrids. The human /)-galactosidase 
locus maps to chromosome 3p21-3pter (Fig. 6). 
FIG. 4. Nucleotide sequence of /)-galactosidase cDNA and the deduced amino acid sequence. Lower-case letters indi-
cate 5' and 3' untranslated sequence. Boxes denote differences in sequence from that ·reported by Oshima et al. (1988). 
The bold arrow (I) demarcates the proposed signal sequence cleavage site. Asterisks (*) denote potential glycosylation 
sites. Numbered and underlined peptides are those determined by chemical sequencing of pure /)-galactosidase (Fig. 2). 







FIG. 5. Northern blot analysis of lymphoblast (L) and 
testicular (T) poly(A)RNA. Samples (1 µg) of poly(A)RNA 
were run on a 1 % formaldehyde/agarose gel and blotted 
using labeled RNA from clone 6 as probe. Size standards 
are the 0.24 to 9.5-kb RNA ladder (Bethesda Research 
Laboratories). 
DISCUSSION 
Although the sequence of the cDNA for human {J-galac-
tosidase was reported recently (Oshima et al., 1988), addi-
tional information on the {J-galactosidase cDNA remains 
to be determined. Amino acid sequencing of CNBr and 
tryptic peptides confirms the identification of the cDNA 
sequence as that of human {J-galactosidase (Figs. 2, 3, and 
4). All 10 tryptic peptides and the single CNBr peptide are 
located in the amino acid sequence deduced from the nu-
cleotide sequence of clone 16 (Figs. 3 and 4), which is iden-
tical to that reported by Oshima et al. (1988) except for a 
few base changes. 
One of the nucleotide base differences we note occurs at 
nucleotide 89 (Fig. 4), numbered 63 in Oshima's et al. 
(1988) published sequence, where we found thymine rather 
than cytosine. This changes the amino acid at this position, 
which is within the signal peptide sequence, from proline 
to leucine. Another difference is at nucleotide 94, num-
bered 68 in Oshima's et al. (1988) sequence, where we 
found cytosine rather than thymine; no difference in 
amino acid sequence results because both triplets code for 
leucine. Beginning at nucleotide 660 there is a GC region 
where the order of 2 guanosine and 2 cytosine bases is un-
clear, most likely due to intrastrand base pairing that 
causes artifacts in the sequencing gel. Substituting dITP 
for dGTP in the sequencing reaction, we found the se-
quence in this region reads GCGC, resulting in the incor-
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FIG. 6. Hybridization of the {J-galactosidase clone 6 
probe to human-mouse somatic cell hybrids. Human (lane 
6) and mouse (lane 5) DNA digested with Eco RI yield dis-
tinguishable patterns. Somatic cell hybrids are either posi-
tive for the human fragments (lanes 1, 3, and 4) or nega-
tive (lane 2). Lane 1 is TSL-2, a hybrid containing the 
p21-pter region of chromosome 3. Lanes 2 and 3 have both 
parts of a reciprocal translocation: XTR-22 (lane 2) con-
tains 3q21-3qter and XTR-3BSAGB (lane 3) contains 
3pter-3q21. Lane 4 contains a hybrid whose only human 
chromosome is 3. These data place the 5.5-, 2.9-, and 1.3-
kb Eco RI fragments hybridizing to clone 6 in the p21-pter 
region of chromosome 3. 
poration of amino acid argmme rather than alanine as 
noted in Oshima's et al. (1988) sequence. The sequence of 
the protein described in Fig. 4 was compared with se-
quences in the protein database and no significant homol-
ogy was detected. 
The presence of a second cDNA of slightly differenc 
structure opens the possibility of two different mRNA spe-
cies coding for similar proteins. Northern blot analysis 
with a probe spanning a region common to both species 
(Fig. 3, clone 6) reveals the presence of only a single 
mRNA species of 2.45 kb in human lymphoblasts and hu-
man testicular tissue. On the basis of the present evidence, 
we believe that the larger cDNA species codes for the 2.45-
kb mRNA transcript which is translated into human {J-ga-
lactosidase. Because the sequence of the shorter clone 23 
does not code for two of the peptides found during aminu 
acid sequence analysis (Fig. 3, peptides 2 and 8), the 
mRNA from clone 16 must be responsible for the signal on 
the Northern blot. The significance of the shorter cDN.A is 
unclear. 
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FIG. 7. Proposed structure of the 13-galactosidase cDNA. The open box represents the open reading frame while the 
solid lines represent untranslated regions. The numbered dashes ( - ) under the cDNA structure indicate the location of 
the 11 sequenced peptides from Fig. 2. Stars (*) indicate potential glycosylation sites. The bold arrow ()) indicates a po-
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HG. 8. Hydrophobicity plot of human 13-galactosidase using the method of Kyte and Doolittle (1982). Sequence evalu-
ated contains 677 amino acids. A potential cleavage site is present around amino acid 530 in a hydrophilic region. 
Previously, Shows et al. (1979) used human-mouse hy-
brids and species-specific anti-13-galactosidase antiserum to 
identify the locus coding for human 13-galactosidase and 
assigned the gene to chromosome 3. Naylor et al. (1982) 
used the same antibody to place the 13-galactosidase locus 
in the region 3p21-3q21. However, TSL-6F, the hybrid cell 
line used to locate the gene previously exhibits a very weak 
hybridization signal with the 13-galactosidase probe (clone 
6). The expression of the human 13-galactosidase protein in 
TSL-6F is probably too weak to be detected reliably. This 
accounts for the lack of immunoreactivity with TSL-6F in 
the previous study. Consequently, these new results are not 
in conflict with the earlier report. 
Jones et al. (1984) have placed the 13-galactosidase gene 
in the cen-pter region, and recently, Hertz et al. (1988) ex-
cluded 3pl 1-3p14.2. All the data are now consistent with 
the human 13-galactosidase gene being located in the 3p21-
3pter region. 
It has been reported that 13-galactosidase is initially syn-
thesized as an 84-kD precursor which is processed to an in-
termediate form of 88 kD and then to a 64-kD mature en-
zyme form (Nanba et al., 1988). We reported previously 
that the 64-kD mature enzyme contains 7.511/o carbohy-
drate (Frost et al., 1978) which gives a molecular weight of 
the polypeptide portion of the mature enzyme of 59 kD. 
The deduced amino acid sequence of 13-galactosidase yields 
a protein of 73.5 kD after cleavage of the putative signal 
peptide (Oshima et al., 1988), suggesting that proteolytic 
cleavage removes about 15 kD of polypeptide. Based on 
the positions of the peptides determined here from amino 
acid sequencing (Fig. 7), most of the proteolytic processing 
must occur at the carboxyl terminus of the precursor pro-
tein. 
Although we found that the amino terminus of the ma-
ture enzyme was blocked, preventing sequence identifica-
tion of the initial residues, one tryptic peptide was located 
126 
8 amino acid residues from the predicted signal cleavage 
site. No peptides were identified in the mature enzyme, 
that were derived from the carboxy-terminal residues (after 
residue 492) of the precursor sequence. When the deduced 
amino acid sequence of the precursor is analyzed on a 
Kyte-Doolittle hydrophobicity plot (Kyte and Doolittle, 
1982), a large hydrophilic region is noticeable in the area 
of amino acid 530 (Fig. 8). If we assume that this is the re-
gion where proteolytic cleavage occurs, a protein of ap-
proximately 58 kD is generated which contains the entire 
region coding for the 11 peptides found by chemical se-
quencing (Figs. 4 and 7). Three potential glycosylation 
sites also are present in the region we believe is processed, 
which, if glycosylated, could account for some additional 
mass removed during processing (Figs. 4 and 7). 
It has recently been suggested that the protective protein 
that stabilizes {j-galactosidase may do so by proteolytic 
modification of {j-galactosidase at its carboxyl terminus 
(Galjart et al., 1988). The cDNA encoding the protective 
protein precursor has been isolated and sequenced (Galjart 
et al., 1988). Extensive homology between the protective 
protein and the yeast proteases carboxypeptidase Y and 
KEXl was found, including conserved stretches that con-
tain the three active-site residues (Galjart et al., 1988), sug-
gesting that the former is also a serine protease. The car-
boxy cleavage region close to amino acid residue 530 in {j-
galactosidase may be the site where protective protein 
cleaves {j-galactosidase to stabilize it and prevent its intra-
lysosomal degradation. 
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NOTE ADDED IN PROOF 
While this paper was in press, H. Morreau et al. (1989) 
(J. Biol. Chem. 264, 20655-20663) reported the isolation 
and sequencing of two cDNAs encoding human {3-galac-
tosidase. They identified the same short cDNA as we dis-
covered (the two sequences are identical) as well as the 
longer cDNA, and demonstrated that the shorter cDNA is 
produced by alternative splicing of {3-galactosidase mRNA. 
Small amounts of mRNA corresponding to the shorter 
cDNA were detected in some human tissues. 
